Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

NCT05869201 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

450

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza
Influenza, Human
Influenza Viral Infections
Vaccine Reaction
Vaccination; Infection

Interventions

BIOLOGICAL: Influenza vaccine [inactivated]
BIOLOGICAL: Influenza vaccine [inactivated]
BIOLOGICAL: Influenza vaccine [inactivated]

Sponsor

St. Petersburg Research Institute of Vaccines and Sera